16 January 2024 - Fenfluramine costs more than $3,000 a month and is not approved by Health Canada.
It's been an agonising wait for the family of a young Sudbury, Ontario girl with a rare form of epilepsy called Dravet syndrome, but the promise of access to a new drug is giving them hope.